Use of Retinoid Receptor Ligands to Identify Other Nuclear Receptor Ligands

[1]  A. Rishi,et al.  Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R , 2013, PloS one.

[2]  M. Gobbi,et al.  New insights into the molecular mechanisms underlying sensitivity/resistance to the atypical retinoid ST1926 in acute myeloid leukaemia cells: the role of histone H2A.Z, cAMP-dependent protein kinase A and the proteasome. , 2013, European journal of cancer.

[3]  P. Portincasa,et al.  A Pleiotropic Role for the Orphan Nuclear Receptor Small Heterodimer Partner in Lipid Homeostasis and Metabolic Pathways , 2012, Journal of lipids.

[4]  T. Hadden,et al.  Adamantyl Retinoid-Related Molecules Induce Apoptosis in Pancreatic Cancer Cells by Inhibiting IGF-1R and Wnt/β-Catenin Pathways , 2012, Journal of oncology.

[5]  John Calvin Reed,et al.  Analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid. 2. Impact of 3-chloro group replacement on inhibition of proliferation and induction of apoptosis of leukemia and cancer cell lines. , 2012, Journal of medicinal chemistry.

[6]  Li Wang,et al.  Role of nuclear receptor SHP in metabolism and cancer. , 2011, Biochimica et biophysica acta.

[7]  John Calvin Reed,et al.  Heteroatom-substituted analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid. , 2011, Journal of medicinal chemistry.

[8]  G. Giannini,et al.  New retinoid derivatives as back-ups of Adarotene. , 2011, Bioorganic & medicinal chemistry.

[9]  Jiansheng Huang,et al.  Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[10]  R. Mohammad,et al.  Adamantyl-Substituted Retinoid-Related Molecules Induce Apoptosis in Human Acute Myelogenous Leukemia Cells , 2010, Molecular Cancer Therapeutics.

[11]  Li Wang,et al.  Insights into the binding mode and mechanism of action of some atypical retinoids as ligands of the small heterodimer partner (SHP) , 2010, J. Comput. Aided Mol. Des..

[12]  A. Rishi,et al.  Novel cis-trans interactions are involved in post-transcriptional regulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1 mRNA , 2010, Journal of molecular signaling.

[13]  M. Dawson,et al.  The peptidomimetic, 1-adamantyl-substituted, and flex-het classes of retinoid-derived molecules: structure-activity relationships and retinoid receptor-independent anticancer activities. , 2010, Mini reviews in medicinal chemistry.

[14]  In-kyu Lee,et al.  Targeting orphan nuclear receptor SHP in the treatment of metabolic diseases , 2010, Expert opinion on therapeutic targets.

[15]  M. Zucchetti,et al.  Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  Li Ping Xu,et al.  Derivation of a Retinoid X Receptor Scaffold from Peroxisome Proliferator‐Activated Receptor γ Ligand 1‐Di(1H‐indol‐3‐yl)methyl‐4‐trifluoromethylbenzene , 2009, ChemMedChem.

[17]  M. Dawson,et al.  SHP and Sin3A expression are essential for adamantyl-substituted retinoid-related molecule–mediated nuclear factor-κB activation, c-Fos/c-Jun expression, and cellular apoptosis , 2009, Molecular Cancer Therapeutics.

[18]  A. Jungbauer,et al.  Peroxisome proliferator-activated receptor gamma is constitutively activated in yeast. , 2009, Analytical biochemistry.

[19]  John Calvin Reed,et al.  A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. , 2008, Cancer cell.

[20]  E. Erba,et al.  Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity , 2008, Molecular Cancer Therapeutics.

[21]  M. Dawson,et al.  Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domain-containin , 2008, Journal of medicinal chemistry.

[22]  T. Nakanishi.  Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor. , 2008, The Journal of toxicological sciences.

[23]  Osman A. B. S. M. Gani,et al.  Ligand‐Induced Stabilization and Activation of Peroxisome Proliferator‐Activated Receptor γ , 2008, Chemical biology & drug design.

[24]  Hueng-Sik Choi,et al.  Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner. , 2008, Endocrine journal.

[25]  N. Noy.  Ligand specificity of nuclear hormone receptors: sifting through promiscuity. , 2007, Biochemistry.

[26]  I. Palmeirim,et al.  Chick Hairy1 protein interacts with Sap18, a component of the Sin3/HDAC transcriptional repressor complex , 2007, BMC Developmental Biology.

[27]  T. Mustelin,et al.  An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: effects of modifying its carboxylate group on apoptosis, proliferation, and protein-tyrosine phosphatase activity. , 2007, Journal of medicinal chemistry.

[28]  Xiao-kun Zhang.  Targeting Nur77 translocation , 2007, Expert opinion on therapeutic targets.

[29]  John Calvin Reed,et al.  Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt , 2006, Oncogene.

[30]  K. Pearce,et al.  The Nuclear Receptor Superfamily and Drug Discovery , 2006, ChemMedChem.

[31]  S. Fiorucci,et al.  Unveiling hidden features of orphan nuclear receptors: the case of the small heterodimer partner (SHP). , 2006, Journal of molecular graphics & modelling.

[32]  M. Dawson,et al.  Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-kappaB activation. , 2005, Cancer research.

[33]  M. Dawson,et al.  Retinoid X Receptor Regulates Nur77/Thyroid Hormone Receptor 3-Dependent Apoptosis by Modulating Its Nuclear Export and Mitochondrial Targeting , 2004, Molecular and Cellular Biology.

[34]  Ji Miao,et al.  Role of an mSin3A-Swi/Snf Chromatin Remodeling Complex in the Feedback Repression of Bile Acid Biosynthesis by SHP , 2004, Molecular and Cellular Biology.

[35]  A. Rishi,et al.  Antagonist analogue of 6-[3'-(1-adamantyl)-4'-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest. , 2004, Journal of medicinal chemistry.

[36]  T. Willson,et al.  Polyunsaturated Fatty Acids Including Docosahexaenoic and Arachidonic Acid Bind to the Retinoid X Receptor α Ligand-binding Domain* , 2004, Molecular & Cellular Proteomics.

[37]  M. Shong,et al.  Differential role of the loop region between helices H6 and H7 within the orphan nuclear receptors small heterodimer partner and DAX-1. , 2004, Molecular endocrinology.

[38]  Ying Huang,et al.  Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities , 2004, Oncogene.

[39]  John Calvin Reed,et al.  Conversion of Bcl-2 from Protector to Killer by Interaction with Nuclear Orphan Receptor Nur77/TR3 , 2004, Cell.

[40]  M. Pfahl,et al.  Retinoid targets for apoptosis induction , 2003, Oncogene.

[41]  R. Mohammad,et al.  Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog. , 2003, Blood.

[42]  N. Noy,et al.  Retinoic Acid Is a High Affinity Selective Ligand for the Peroxisome Proliferator-activated Receptor β/δ* , 2003, Journal of Biological Chemistry.

[43]  R. Mohammad,et al.  Identification and Characterization of a Cell Cycle and Apoptosis Regulatory Protein-1 as a Novel Mediator of Apoptosis Signaling by Retinoid CD437* , 2003, Journal of Biological Chemistry.

[44]  F. Gao,et al.  Inhibition of IκB Kinase by a New Class of Retinoid-Related Anticancer Agents That Induce Apoptosis , 2003, Molecular and Cellular Biology.

[45]  M. Kirschner,et al.  Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway. , 2002, Cancer research.

[46]  J. Gustafsson,et al.  A transcriptional inhibitor targeted by the atypical orphan nuclear receptor SHP , 2002, EMBO reports.

[47]  P. Weber,et al.  Phytanic acid, a natural peroxisome proliferator‐activated receptor agonist, regulates glucose metabolism in rat primary hepatocytes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  T. Eberlein,et al.  Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN) , 2001, Cell Death and Differentiation.

[49]  M. Dawson,et al.  Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity. , 2001, Cancer research.

[50]  D. Moras,et al.  Crystal Structure of the Ligand-binding Domain of the Ultraspiracle Protein USP, the Ortholog of Retinoid X Receptors in Insects* , 2001, The Journal of Biological Chemistry.

[51]  T. Perlmann,et al.  Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. , 2000, Science.

[52]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[53]  W. Hong,et al.  Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells. , 2000, Cancer research.

[54]  John Calvin Reed,et al.  Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. , 2000, Science.

[55]  A. Rishi,et al.  Identification of a unique binding protein specific for a novel retinoid inducing cellular apoptosis , 2000, International journal of cancer.

[56]  A. Rishi,et al.  S-phase arrest and apoptosis induced in normal mammary epithelial cells by a novel retinoid. , 2000, Cancer research.

[57]  J. Thomsen,et al.  The Orphan Nuclear Receptor SHP Utilizes Conserved LXXLL-Related Motifs for Interactions with Ligand-Activated Estrogen Receptors , 2000, Molecular and Cellular Biology.

[58]  P. Chambon,et al.  Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. , 2000, Molecular cell.

[59]  M. Sheikh,et al.  Post-transcriptional regulation of the DNA damage-inducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid CD437. , 1999, Nucleic acids research.

[60]  M. Sheikh,et al.  Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid. , 1999, Experimental cell research.

[61]  M. Dawson,et al.  Synthetic retinoid CD437 induces S‐phase arrest and apoptosis in human prostate cancer cells LNCaP and PC‐3 , 1999, The Prostate.

[62]  U. Dräger,et al.  Retinoid-binding proteins in the cerebellum and choroid plexus and their relationship to regionalized retinoic acid synthesis and degradation. , 1998, European journal of biochemistry.

[63]  John Calvin Reed,et al.  Molecular Determinants of AHPN (CD437)-Induced Growth Arrest and Apoptosis in Human Lung Cancer Cell Lines , 1998, Molecular and Cellular Biology.

[64]  P. Reczek,et al.  Serine 232 and Methionine 272 Define the Ligand Binding Pocket in Retinoic Acid Receptor Subtypes* , 1998, The Journal of Biological Chemistry.

[65]  R. Chandraratna,et al.  Lack of involvement of retinoic acid receptor alpha in retinoid-induced skin irritation in hairless mice. , 1997, Toxicology letters.

[66]  A. Rishi,et al.  Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. , 1997, Blood.

[67]  Q. Wu,et al.  Effects of receptor class- and subtype-selective retinoids and an apoptosis-inducing retinoid on the adherent growth of the NIH:OVCAR-3 ovarian cancer cell line in culture. , 1997, Cancer letters.

[68]  A. Rishi,et al.  Bcl-XLExpression and Its Downregulation by a Novel Retinoid in Breast Carcinoma Cells , 1997 .

[69]  R. Lotan,et al.  Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6‐[3‐(1‐adamantyl)hydroxyphenyl]‐2‐naphtalene carboxylic acid (CD437) , 1997, International journal of cancer.

[70]  X. -. Li,et al.  Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells. , 1996, Cancer research.

[71]  D. Moore,et al.  An Orphan Nuclear Hormone Receptor That Lacks a DNA Binding Domain and Heterodimerizes with Other Receptors , 1996, Science.

[72]  P. Lemotte,et al.  Phytanic acid is a retinoid X receptor ligand. , 1996, European journal of biochemistry.

[73]  William Bourguet,et al.  A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.

[74]  B. Shroot,et al.  Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. , 1995, Journal of medicinal chemistry.

[75]  Jean-Paul Renaud,et al.  Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.

[76]  K. R. Ely,et al.  Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. , 1995, Cancer research.

[77]  M. Pfahl,et al.  Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. , 1995, Journal of medicinal chemistry.

[78]  M. Sheikh,et al.  p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. , 1995, Oncogene.

[79]  M. Boehm,et al.  Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. , 1995, Journal of medicinal chemistry.

[80]  K. Robertson,et al.  Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. , 1992, Blood.

[81]  B. Shroot,et al.  Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gamma. , 1992, Biochemical and biophysical research communications.

[82]  C. Clarke,et al.  Expression and regulation of retinoic acid receptors in human breast cancer cells. , 1992, Cancer research.

[83]  A. V. van Kessel,et al.  The cellular retinoic-acid-binding protein is expressed in tissues associated with retinoic-acid-induced malformations. , 1990, Development.

[84]  J. Hathcock,et al.  Evaluation of vitamin A toxicity. , 1990, The American journal of clinical nutrition.

[85]  S. Collins,et al.  Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha) , 1990, Molecular and cellular biology.

[86]  M. Sporn,et al.  Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. , 1983, Cancer research.

[87]  M. Dawson,et al.  Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation , 2011, Cell Death and Differentiation.

[88]  I. McEwan.  Nuclear receptors: one big family. , 2009, Methods in molecular biology.

[89]  D. Moore,et al.  Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor. , 2007, Cancer research.

[90]  Yong-soo Lee,et al.  Structure and function of the atypical orphan nuclear receptor small heterodimer partner. , 2007, International review of cytology.

[91]  L. Diomede,et al.  ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. , 2004, Blood.

[92]  R. Spanjaard,et al.  The apoptotic action of the retinoid CD437/AHPN: diverse effects, common basis. , 2003, Journal of biomedical science.

[93]  K. Bhalla,et al.  Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid. , 1998, Oncology research.

[94]  B. Shroot,et al.  Selective synthetic ligands for human nuclear retinoic acid receptors. , 1992, Skin pharmacology : the official journal of the Skin Pharmacology Society.